Review
Published on 04 Apr 2022
TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
in Cancer Molecular Targets and Therapeutics
- 8,540 views
- 21 citations
Review
Published on 04 Apr 2022
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 04 Apr 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 04 Apr 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 31 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 31 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 31 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 30 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 28 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 25 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 25 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 25 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics